Denali Therapeutics
DNLI
DNLI
212 hedge funds and large institutions have $3.8B invested in Denali Therapeutics in 2021 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 85 increasing their positions, 62 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $4.28B → $3.8B (-$480M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
77% less call options, than puts
Call options by funds: $2.6M | Put options by funds: $11.3M
Holders
212
Holding in Top 10
2
Calls
$2.6M
Puts
$11.3M
Top Buyers
| 1 | +$24.8M | |
| 2 | +$24.5M | |
| 3 | +$18.9M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$17.7M |
| 5 |
YCM
Yiheng Capital Management
San Francisco,
California
|
+$14.9M |
Top Sellers
| 1 | -$51.1M | |
| 2 | -$28.8M | |
| 3 | -$20M | |
| 4 |
CC
Casdin Capital
New York
|
-$8.92M |
| 5 |
Two Sigma Advisers
New York
|
-$6.76M |